BMO Capital Opines on Possible Bristol-Myers (BMY) Acquisition

February 21, 2017 9:06 AM EST Send to a Friend
BMO Capital maintains Market Perform on Bristol-Myers Squibb Co. (NYSE: BMY) price target of $45.00.Analyst Alex Arfaei comments "We've recently ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login